Novo Nordisk said on Monday (Nov 18) it has launched its popular obesity drug Wegovy in China, the world’s second-largest pharmaceuticals market. A spokesperson for the Danish drugmaker confirmed the ...

More than 9million prescriptions for Ozempic and similar weight loss drugs are written every year in the US, estimates suggest - which is one of the world's fattest nations.

The makers of Ozempic and Zepbound are fighting to stop compounded copies of their drugs. But it’s unclear whether they can ...

U.S. government health plans account for the lion's share of coverage for popular new weight-loss drugs, far beyond the ...

KOLs interviewed by GlobalData think that semaglutide can be a treatment option for non-diabetic CKD patients whose kidney ...

Novo Nordisk (NVO) has reportedly launched its popular weight-loss drug Wegovy in China ahead of a rival drug by Eli Lilly ...

State Medicaid programs for low-income families are the single biggest source of coverage, giving 31.6 million people access ...

W hen president-elect Donald Trump announced that he would nominate Robert F Kennedy Jr to be his secretary of Health and Human Services, the move shocked many. Kennedy, the son of the late senator ...

Here, five nutrition experts review seven foods and drinks to limit or avoid when taking Ozempic and why reducing them may ...

Should he make it through the nomination process, Kennedy plans to follow Trump’s mandate to remove “corruption” from HHS-led ...

Wegovy is being made available to Chinese patients five months after its approval in the country. Novo will sell the medicine ...

The luxury goods market is slowing down as 50 million consumers cut back with brands needing reinvention to meet rising expectations, especially from Gen Z.